Table 1 Patient characteristics and tumor pathology (n = 183) [*average]
From: [18F]FDG-PET/CT-based risk stratification in women with locally advanced uterine cervical cancer
|  | Studied cohort (n = 183) | Kidd cohort (n = 234) |
|---|---|---|
Age (years) median [range] | 53.91 [22.09–87.74] | 52* [24–94] |
Follow up (months) median [range] | 44.91 [1.87-101.52] | 40.7* [5-125] |
FIGO 2009 stage | ||
IB2 | 32 (17.5%) | 36 (15%) |
IIA | 19 (10.3%) | 5 (2%) |
IIB | 69 (37.7%) | 102 (43.6%) |
IIIA | 7 (3.8%) | 3 (1.3%) |
IIIB | 39 (21.3%) | 56 (23.9%) |
IVA | 11 (6.0%) | 3 (1.3%) |
IVB | 6 (3.3%) | 0 |
FIGO 2018 stage | ||
IB2 | 2 (1.1%) | n.a. |
IB3 | 7 (3.8%) | n.a. |
IIA | 10 (5.5%) | n.a. |
IIB | 34 (18.6%) | n.a. |
IIIA | 4 (2.2%) | n.a. |
IIIB | 15 (8.2%) | n.a. |
IIIC1 | 68 (37.1%) | n.a. |
IIIC2 | 32 (17.5%) | n.a. |
IVA | 4 (2.2%) | n.a. |
IVB | 7 (3.8%) | n.a. |
Histology | ||
Squamous cell carcinoma (SCC) | 154 (84.2%) | 207 (88%) |
Adenocarcinoma | 17 (9.3%) | 16 (7%) |
Adenosquamous carcinoma | 5 (2.7%) | 4 (2%) |
Other | 7 (3.8%) | 7 (3%) |